Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Neoplasms × Lidocaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Neoplasms 12 Pain 11 Colorectal Neoplasms 11 Pain, Postoperative 9 Prostatic Neoplasms 7 Lung Neoplasms 7 Cancer Pain 5 Agnosia 5 Neuralgia 4 Keratosis, Actinic 4 Head and Neck Neoplasms 4 Colonic Neoplasms 4 Liver Neoplasms 3 Chronic Pain 3 Stomatitis 2 Stomach Neoplasms 2 Recurrence 2 Pilonidal Sinus 2 Oropharyngeal Neoplasms 2 Myofibroma 2 Mucositis 2 Leiomyoma 2 Ileus 2 Carcinoma, Non-Small-Cell Lung 2 Wounds and Injuries 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Tuberculosis 1 Thyroid Neoplasms 1

Interventions

Paclitaxel 12 pembrolizumab 8 Carboplatin 7 Surveys and Questionnaires 6 Cisplatin 5 Doxorubicin 4 Docetaxel 4 Brachytherapy 4 Gemcitabine 3 FANG vaccine 3 olaparib 2 durvalumab 2 Topotecan 2 Sentinel Lymph Node Biopsy 2 Saline Solution 2 Radiotherapy 2 Radiation 2 Pemetrexed 2 Oxaliplatin 2 Music Therapy 2 Mitomycin 2 Leucovorin 2 Letrozole 2 Imagery, Psychotherapy 2 Hysterectomy 2 Hyperthermic Intraperitoneal Chemotherapy 2 Fluorouracil 2 Exercise 2 CP protocol 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01492179 2014-05-28

PoPuLAR

Örebro University, Sweden

Phase 4 Completed

Pain, Postoperative, Uterine Neoplasms, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡